{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:22:57Z","timestamp":1700241777535},"reference-count":17,"publisher":"American Diabetes Association","issue":"10","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:p>OBJECTIVE\u2014The aim of this study was to determine personal characteristics and preferences that affect decision making (decisional attributes) in patients with diabetes. In particular, we were interested in relating these attributes to the choice of using aspirin to reduce cardiovascular risk.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014We conducted a cross-sectional survey (70% response rate) of 206 diabetic patients (median age, 63 years; 42% women; 91% completed high school; median HbA1c, 8%) attending a tertiary care diabetes clinic. Patients answered a 42-question survey exploring decisional attributes. Medical records provided the source of clinical information. We evaluated sociodemographic, clinical, and decisional predictors of aspirin use. We also conducted a multivariable analysis with aspirin use as a dependent variable.<\/jats:p>\n               <jats:p>RESULTS\u2014Sixty-seven percent of patients surveyed used aspirin. Patients using aspirin were at higher risk of cardiovascular disease (odds ratio 1.4, 95% CI 1.0\u20132.1), knew more about the benefits of aspirin (1.9, 1.4\u20132.6) and less about the risks of aspirin (1.4, 1.2\u20131.8), and were more certain about using aspirin (0.5, 0.3\u20130.8) than patients not using aspirin. Patients using aspirin placed a higher value on preventing cardiovascular events than on avoiding the side effects of aspirin. Patients perceived that their diabetes provider and the American Diabetes Association had greater influence on their decision to use aspirin than family members or other patients with diabetes.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014The decisional attributes of patients with diabetes are associated with aspirin use. Decisional attributes may be the target of research and interventions to reduce underutilization to levels consistent with patient preferences.<\/jats:p>","DOI":"10.2337\/diacare.26.10.2804","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"2804-2809","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":9,"title":["Decisional Attributes of Patients With Diabetes"],"prefix":"10.2337","volume":"26","author":[{"given":"Victor M.","family":"Montori","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra C.","family":"Bryant","sequence":"additional","affiliation":[{"name":"Section of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal W.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Section of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Mayo Medical School, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Health Care Policy and Research and Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031217531799000_R1","doi-asserted-by":"crossref","unstructured":"Fagot-Campagna A, Gary TL, Benjamin SM: Cardiovascular risk in diabetes: a story of missed opportunities? Diabetes Care\u200824:2015\u20132016, 2001","DOI":"10.2337\/diacare.24.11.2015"},{"key":"2022031217531799000_R2","doi-asserted-by":"crossref","unstructured":"Meigs JB, Stafford RS: Cardiovascular disease prevention practices by U.S. physicians for patients with diabetes. J Gen Intern Med\u200815:220\u2013228, 2000","DOI":"10.1111\/j.1525-1497.2000.03079.x"},{"key":"2022031217531799000_R3","doi-asserted-by":"crossref","unstructured":"Stafford RS, Radley DC: The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol\u200841:56\u201361, 2003","DOI":"10.1016\/S0735-1097(02)02670-0"},{"key":"2022031217531799000_R4","doi-asserted-by":"crossref","unstructured":"O\u2019Connor AM, Jacobsen MJ, Stacey D: An evidence-based approach to managing women\u2019s decisional conflict. J Obstet Gynecol Neonatal Nurs\u200831:570\u2013581, 2002","DOI":"10.1111\/j.1552-6909.2002.tb00083.x"},{"key":"2022031217531799000_R5","unstructured":"O\u2019Connor AM, Stacey D, Rovner D, Holmes-Rovner M, Tetroe J, Llewellyn-Thomas H, Entwistle V, Rostom A, Fiset V, Barry M, Jones J: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev CD001431, 2001"},{"key":"2022031217531799000_R6","doi-asserted-by":"crossref","unstructured":"O\u2019Connor AM: Validation of a decisional conflict scale. Med Decis Making\u200815:25\u201330, 1995","DOI":"10.1177\/0272989X9501500105"},{"key":"2022031217531799000_R7","doi-asserted-by":"crossref","unstructured":"Strull WM, Lo B, Charles G: Do patients want to participate in medical decision making? JAMA\u2008252:2990\u20132994, 1984","DOI":"10.1001\/jama.252.21.2990"},{"key":"2022031217531799000_R8","doi-asserted-by":"crossref","unstructured":"Degner LF, Sloan JA, Venkatesh P: The Control Preferences Scale. Can J Nurs Res\u200829:21\u201343, 1997","DOI":"10.1037\/t22188-000"},{"key":"2022031217531799000_R9","unstructured":"O\u2019Connor PJ, Pronk NP, Tan AW, Rush WA, Gray RJ: Does professional advice influence aspirin use to prevent heart disease in an HMO population? Eff Clin Pract\u20081:26\u201332, 1998"},{"key":"2022031217531799000_R10","doi-asserted-by":"crossref","unstructured":"Krein SL, Vijan S, Pogach LM, Hogan MM, Kerr EA: Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care\u200825:965\u2013970, 2002","DOI":"10.2337\/diacare.25.6.965"},{"key":"2022031217531799000_R11","doi-asserted-by":"crossref","unstructured":"Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, Nagpal S, Cox JL: Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ\u2008323:1218\u20131222, 2001","DOI":"10.1136\/bmj.323.7323.1218"},{"key":"2022031217531799000_R12","doi-asserted-by":"crossref","unstructured":"Colwell JA: Aspirin therapy in diabetes. Diabetes Care\u200826 (Suppl 1):S87\u2013S88, 2003","DOI":"10.2337\/diacare.26.2007.S87"},{"key":"2022031217531799000_R13","doi-asserted-by":"crossref","unstructured":"Charles C, Gafni A, Whelan T: Decision making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med\u200849:651\u2013661, 1999","DOI":"10.1016\/S0277-9536(99)00145-8"},{"key":"2022031217531799000_R14","doi-asserted-by":"crossref","unstructured":"Charles C, Gafni A, Whelan T: Shared decision making in the medical encounter: what does it mean (or it takes at least two to tango). Soc Sci Med\u200844:681\u2013692, 1997","DOI":"10.1016\/S0277-9536(96)00221-3"},{"key":"2022031217531799000_R15","doi-asserted-by":"crossref","unstructured":"Charles C, Redko C, Whelan T, Gafni A, Reyno L: Doing nothing is no choice: lay constructions of treatment decision making among women with early-stage breast cancer. Sociol Health Illn\u200820:71\u201395, 1998","DOI":"10.1111\/1467-9566.00081"},{"key":"2022031217531799000_R16","doi-asserted-by":"crossref","unstructured":"Hayden M, Pignone M, Phillips C, Mulrow C: Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med\u2008136:161\u2013172, 2002","DOI":"10.7326\/0003-4819-136-2-200201150-00016"},{"key":"2022031217531799000_R17","doi-asserted-by":"crossref","unstructured":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ\u2008324:71\u201386, 2002","DOI":"10.1136\/bmj.324.7329.71"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/10\/2804\/590394\/dc1003002804.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/10\/2804\/590394\/dc1003002804.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:47:35Z","timestamp":1647110855000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/26\/10\/2804\/26117\/Decisional-Attributes-of-Patients-With-DiabetesThe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.26.10.2804","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}